Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger
Stigma attributed to symptoms had a stronger negative association with psychosocial variables than did labelling-related stigma among individuals recently identified as CHR-p. That secrecy related to the CHR-p designation was greater than its symptom-related counterpart suggests that labelling-related stigma may still be problematic for some CHR-p participants. To optimise this pivotal early intervention effort, interventions should address the holistic 'stigmatising experience' of having symptoms, namely any harmful reactions received as well as participants' socially influenced concerns about what their experiences mean, in addition to the symptoms themselves.
Authors
- Margaux M. Grivel
- Debbie Huang (ORCID: https://orcid.org/0000-0002-7813-7942)
- Drew Blasco (ORCID: https://orcid.org/0000-0003-2524-5066)
- Cheryl M. Corcoran (ORCID: https://orcid.org/0000-0002-8902-4353)
- Bruce G. Link (ORCID: https://orcid.org/0000-0001-9980-7450)
- Ragy R. Girgis (ORCID: https://orcid.org/0000-0001-5715-8982)
- Kristen A. Woodberry (ORCID: https://orcid.org/0000-0001-8282-1803)
- Lawrence Hsin Yang (ORCID: https://orcid.org/0000-0001-7779-7423)
- William R. McFarlane (ORCID: https://orcid.org/0000-0003-2694-9057)
Institutions
- University of California, Riverside (US)
- Tufts University (US)
- Beth Israel Deaconess Medical Center (US)
- University of Nevada, Las Vegas (US)
- MaineHealth (US)
- Mental Illness Research, Education and Clinical Centers (US)
- Maine Medical Center (US)
- New York State Psychiatric Institute
- New York University (US)
- California State University, Long Beach (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The British Journal of Psychiatry
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1192/bjp.2024.209
- Citations
- 4
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.54
Funders
- Sidney R. Baer, Jr. Foundation
- Harvard T.H. Chan School of Public Health
- Maine Medical Center Research Institute
- National Alliance for Research on Schizophrenia and Depression
- Massachusetts Department of Mental Health
- Otsuka Pharmaceutical
- National Institutes of Health
- Genentech
- Allergan Foundation
- Allergan
- National Institute of Mental Health
- National Human Genome Research Institute
- NIH Clinical Center